Le Lézard
Classified in: Health, Science and technology
Subject: MAV

/R E P E A T -- Media advisory - Government of Canada to announce major milestone in the Biomanufacturing and Life Sciences Strategy/


MONTRÉAL, Aug. 9, 2021 /CNW/ - The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry will announce a major milestone in the Government of Canada's Biomanufacturing and Life Sciences Strategy to position Canada as an mRNA centre of excellence.

A media availability in person and by teleconference will follow the announcement.

Date:

Tuesday, August 10, 2021



Time:

10:00 a.m. (ET)



Location:

Palais des congrès de Montréal


1001 Place Jean-Paul-Riopelle


Montréal, Quebec

Notes for media: 

The announcement will be livestreamed on Innovation, Science and Economic Development Canada's Canadian Science Facebook page.

For media participation on-site:

Media are invited to attend in person. Please comply with local public health guidelines.

A visit of the vaccination site will follow the press conference. Media who wish to attend the site visit are invited to contact ISED Media Relations no later than 5 p.m. on Monday, August 9, 2021, to RSVP.

For media participation virtually:

Media are invited to contact ISED Media Relations no later than 5 p.m. on Monday, August 9, 2021, to receive dial-in information.

Stay connected

Follow Innovation, Science and Economic Development Canada on Twitter: @ISED_CA

SOURCE Innovation, Science and Economic Development Canada


These press releases may also interest you

at 16:20
In the Phase 3 VALOR study, the primary endpoint as measured by the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) did not reach statistical significance; however, signs of reduced disease progression across multiple...

at 16:20
Ionis Pharmaceuticals, Inc. partner Biogen today announced topline results from its placebo-controlled pivotal Phase 3 VALOR study of tofersen (BIIB067), an investigational antisense medicine being evaluated for people with superoxide dismutase 1...

16 oct 2021
Core One Labs Inc. , , (the "Company") a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy, congratulates Seattle's city...

16 oct 2021
Neurocrine Biosciences, Inc.  today announced that it will present key information from its movement disorder treatments for Parkinson's disease and tardive dyskinesia (TD) at the American Neurological Association (ANA) 2021 Virtual Annual Meeting...

16 oct 2021
HLNY's highest recognition, the "Award of Distinction" will be presented to Arthur Gianelli, FACHE, Chief Transformation Officer of Mount Sinai Health System and President of Mount Sinai Morningside. This award recognizes a healthcare executive who...

16 oct 2021
Regulated Information ? Inside Information ? UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that they were unable to complete review of the Biologics License...



News published on 10 august 2021 at 06:00 and distributed by: